Seed Grants
ITMAT plans to support translational research through a TRANSDISCIPLINARY AWARDS PROGRAM IN TRANSLATIONAL MEDICINE AND THERAPEUTICS (TAPITMAT). Initially, we shall consider funding from 4 to 6 proposals in the region of $100,000 - $150,000. These proposals require at least two Co-Principal Investigators, ideally from different disciplines within the University of Pennsylvania, at least one of whom has a primary appointment in the School of Medicine. The proposals must center on the translational space - from proof of concept in cells or model systems through to completion of dose selection in Phase II in humans. Programs that plan to progress within that space and which deploy technologies and approaches conventionally segregated from each other within the traditional boundaries of academic medicine will be especially favored.

2006 TAPITMAT Pilot Grant Recipients

In addition to ITMAT's Pilot Grants and the various internal and external funding opportunities available for investigators, the School of Medicine's Office of Corporate Alliances (OCA) provides the link between Penn Medicine and pharmaceutical, biotechnology and medical-device companies across the world. Forming an alliance affords both partners access to expertise and resources that when combined have the ability to create new knowledge that will more quickly transform patient care. OCA offers access to leading Penn researchers; opportunities in sponsored research, collaborative research, clinical trials and consortiums; and integrated management through functioning as a single point of contact. Because OCA functions within the School of Medicine, it is able to efficiently and effectively identify and follow-through on alliance initiatives. Further information can be obtained directly from the Office of Corporate Alliances website.